BillionToOne Inc at JPMorgan Healthcare Conference Transcript
All right, great. Welcome, everybody, to the J.P. Morgan Healthcare Conference. I'm Casey Woodring from the Life Science Tools and Diagnostics team, pleased to be joined by the management team at BillionToOne. We're going to do the standard 40-minute slot, corporate presentation, Q&A afterwards.
Not much more to be said. Oguzhan, kick it off.
Thank you, Casey. At BillionToOne, we are redefining what is possible with molecular diagnostics, with a technology that, for the first time, achieves single molecule sensitivity and precision. We'd like to talk about our company through four pillars of differentiation that we believe make our company a different type of molecular diagnostics company. We believe that these four pillars are going to make us a category-defining company and the first one in our space to enter S&P 500.
The first pillar, everything that we do, starts with a revolutionary single
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
